Rett Syndrome
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The relationship between this microdeletion syndrome and the congenital variant of Rett syndrome due to point mutations in one of the genes included in the deleted region, FOXG1, is discussed.
|
19303466 |
2009 |
Microcephaly
|
0.500 |
Biomarker
|
disease |
BEFREE |
The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with FOXG1, a gene shown to be involved in a postnatal microcephaly syndrome.
|
29758293 |
2018 |
Rett Syndrome, Atypical
|
0.340 |
Biomarker
|
disease |
BEFREE |
The progressive parting of CDKL5- and FOXG1-gene-related encephalopathies from the core Rett syndrome is reflected by the effort to produce clearer diagnostic criteria for typical and atypical Rett syndrome.
|
22998673 |
2012 |
Rett Syndrome
|
0.300 |
Biomarker
|
disease |
BEFREE |
The progressive parting of CDKL5- and FOXG1-gene-related encephalopathies from the core Rett syndrome is reflected by the effort to produce clearer diagnostic criteria for typical and atypical Rett syndrome.
|
22998673 |
2012 |
Encephalopathies
|
0.070 |
GeneticVariation
|
group |
BEFREE |
The progressive parting of CDKL5- and FOXG1-gene-related encephalopathies from the core Rett syndrome is reflected by the effort to produce clearer diagnostic criteria for typical and atypical Rett syndrome.
|
22998673 |
2012 |
Secondary Neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
The present study aimed at examining the biological function and underlying mechanism of FOXG1 on hepatocellular carcinoma (HCC) tumor metastasis as well as its clinical significance.
|
31771611 |
2019 |
Rett Syndrome
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The position effect involves forkhead box G1 (FOXG1), mutations in which are associated with the congenital form of Rett syndrome and FOXG1 syndrome.
|
29321672 |
2018 |
ovarian neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The overexpression of FOXG1 was significantly correlated with high-grade ovarian cancer (P=0.025).
|
19755996 |
2009 |
Malignant neoplasm of ovary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The overexpression of FOXG1 was significantly correlated with high-grade ovarian cancer (P=0.025).
|
19755996 |
2009 |
Carcinoma, Ovarian Epithelial
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The overexpression of FOXG1 was significantly correlated with high-grade ovarian cancer (P=0.025).
|
19755996 |
2009 |
Encephalopathies
|
0.070 |
Biomarker
|
group |
BEFREE |
The neurological phenotype of FOXG1 haploinsufficiency shows the features of a dyskinetic encephalopathy of infancy.
|
25565401 |
2015 |
Epilepsy
|
0.360 |
Biomarker
|
disease |
BEFREE |
The mean age of epilepsy diagnosis in FOXG1 duplications was significantly younger than those with deletions/intragenic mutations (p = 0.0002).
|
24836831 |
2014 |
Cardiomyopathy, Familial Idiopathic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The identified DEGs (PRSS12 and FOXG1), potential TFs, as well as potential miRNAs, might be involved in DCM.
|
27737314 |
2016 |
FOXG1 syndrome
|
0.790 |
CausalMutation
|
disease |
CLINVAR |
The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy.
|
26344814 |
2016 |
Dysmorphic features
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy.
|
26344814 |
2016 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy.
|
26344814 |
2016 |
Muscle hypotonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy.
|
26344814 |
2016 |
Encephalopathies
|
0.070 |
Biomarker
|
group |
BEFREE |
The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy.
|
26344814 |
2016 |
Epilepsy
|
0.360 |
Biomarker
|
disease |
BEFREE |
The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy.
|
26344814 |
2016 |
Rett Syndrome
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The genetic etiology of RTT without MECP2, CDKL5, and FOXG1 mutations is heterogeneous, overlaps with other NDDs, and complicated by a high mutation burden.
|
27171548 |
2017 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The effect of FOXG1 on cancer cell invasion and metastasis was investigated in vitro and in vivo in either FOXG1-silenced or overexpressing human HCC cell lines.
|
31771611 |
2019 |
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
The effect of FOXG1 on cancer cell invasion and metastasis was investigated in vitro and in vivo in either FOXG1-silenced or overexpressing human HCC cell lines.
|
31771611 |
2019 |
Dysmorphic features
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis.
|
21441262 |
2011 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis.
|
21441262 |
2011 |
Muscle hypotonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis.
|
21441262 |
2011 |